Clinical trials
Recruiting Urinary Bladder Neoplasms trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 2 |
| 2020 | 1 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 6 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 4 |
| Daiichi Sankyo | 2 |
| Eli Lilly and Company | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Amsterdam UMC | 1 |
| Amsterdam UMC, location VUmc | 1 |
| AstraZeneca | 1 |
| Bristol-Myers Squibb | 1 |
| Erasmus Medical Center | 1 |
| Fore Biotherapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder Neoplasms | 20 |
| Lung Neoplasms | 5 |
| Breast Neoplasms | 4 |
| Prostatic Neoplasms | 4 |
| Esophageal Neoplasms | 3 |
| Head and Neck Neoplasms | 3 |
| Non-Muscle Invasive Bladder Neoplasms | 3 |
| Ovarian Neoplasms | 3 |
| Pancreatic Neoplasms | 3 |
| Uterine Cervical Neoplasms | 3 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.